Professor, Medicine, Indiana University School of Medicine
Internal Medicine
Dr. Donald C. Brater, MD
|
|
Give Review
Donald Brater works in the field of Internal Medicine. He graduated from Duke University School of Medicine. Duke University School of Medicine is a top medical college. Duke University School of Medicine is ranked 8/29 in Research/PrimaryCare. He over the years received 1 awards: "Whos Who in Medicine and Healthcare". Donald C. Brater is also a published physician. He has 101 paper published. The most recent paper is: The interaction of diltiazem with lovastatin and pravastatin.
Publications
- Social support and health-related quality of life in chronic heart failure patients.
- Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure.
- Renal effects of cyclooxygenase-2 selective inhibitors.
- Effect of albumin-furosemide mixtures on response to furosemide in cirrhotic patients with ascites.
- Reliability and validity of the compliance belief scales among patients with heart failure.
- Effects of albumin/furosemide mixtures on responses to furosemide in hypoalbuminemic patients.
- Renal effects of COX-2-selective inhibitors.
- Medieval contributions to the search for truth in clinical medicine.
- Healthcare costs of patients with heart failure treated with torasemide or furosemide.
- Intravenous diltiazem and CYP3A-mediated metabolism.
- Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial.
- Clinical pharmacology in the Middle Ages: principles that presage the 21st century.
- Urinary protein binding does not affect response to furosemide in patients with nephrotic syndrome.
- The interaction of diltiazem with simvastatin.
- Pharmacology of diuretics.
- Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition.
- Use of diuretics in cirrhosis and nephrotic syndrome.
- Stereoselective pharmacokinetics of ketoprofen and ketoprofen glucuronide in end-stage renal disease: evidence for a ''futile cycle'' of elimination.
- The interaction of diltiazem with lovastatin and pravastatin.
- Diuretic therapy.
- Effects of NSAIDs on the kidney.
- Role of duration of diuretic effect in preventing sodium retention.
- The effect of nonsteroidal antiinflammatory drugs on electrolyte homeostasis and blood pressure in young and elderly persons with and without renal insufficiency.
- Variable furosemide absorption and poor predictability of response in elderly patients.
- Benefits and risks of torasemide in congestive heart failure and essential hypertension.
- Dopamine does not enhance furosemide-induced natriuresis in patients with congestive heart failure.
- Pharmacodynamics of torsemide administered as an intravenous injection and as a continuous infusion to patients with congestive heart failure.
- Renal toxicity of the nonsteroidal anti-inflammatory drugs.
- Lack of presystemic inversion of (R)- to (S)-ibuprofen in humans.
- Pharmacokinetics and pharmacodynamics of torasemide in patients with chronic renal insufficiency--preliminary evaluation.
- Resistance to diuretics: mechanisms and clinical implications.
- Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide in patients with cirrhosis.
- Pharmacokinetics of didanosine and ketoconazole after coadministration to patients seropositive for the human immunodeficiency virus.
- The pharmacokinetics of piroxicam in elderly persons with and without renal impairment.
- Methotrexate disposition following concomitant administration of ketoprofen, piroxicam and flurbiprofen in patients with rheumatoid arthritis.
- Improving treatment of late life depression in primary care: a randomized clinical trial.
- The pharmacodynamics of torsemide in patients with congestive heart failure.
- The pharmacodynamics of intravenous and oral torsemide in patients with chronic renal insufficiency.
- The pharmacokinetics of intravenous and oral torsemide in patients with chronic renal insufficiency.
- The use of diuretics in congestive heart failure.
- Use of drugs in patients with renal insufficiency. Workshop report.
- Diuretic resistance: mechanisms and therapeutic strategies.
- Pharmacokinetics of loop diuretics in congestive heart failure.
- Depression in late life: the use of clinical characteristics to focus screening efforts.
- Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure.
- Enantioselective disposition of ibuprofen in elderly persons with and without renal impairment.
- Pharmacokinetics and pharmacodynamics of torasemide in health and disease.
- Acute and chronic effects of nonsteroidal antiinflammatory drugs on glomerular filtration rate in elderly patients.
- Pharmacokinetic-dynamic analysis of the indomethacin-furosemide interaction in man.
- Renal excretion of pseudoephedrine.
- Disposition kinetics of ethambutol in man.
- Misuse of cimetidine.
- Effects of indomethacin on furosemide-stimulated urinary PGE2 excretion in man.
- Furosemide in patients with heart failure: shift in dose-response curves.
- Preliminary evaluation of furosemide-probenecid interaction in humans.
- The generic prescribing issue.
- Interaction studies with bumetanide and furosemide. Effects of probenecid and of indomethacin on response to bumetanide in man.
- Electrolyte excretion patterns. Intravenous and oral doses of bumetanide compared to furosemide.
- Variability in derived parameters of furosemide pharmacokinetics.
- Effect of probenecid on response to bumetanide in man.
- Pharmacokinetics of amantadine hydrochloride in subjects with normal and impaired renal function.
- Absorption and disposition of furosemide in congestive heart failure.
- The time course of delivery of furosemide into urine: an independent determinant of overall response.
- Aminoglycoside dosage adjustment in renal failure: a hand-held calculator program.
- Resistance to diuretics: emphasis on a pharmacological perspective.
- Clinical importance of cardiovascular drug interactions.
- Nomograms for drug use in renal disease.
- The pharmacological role of the kidney.
- Systemic alkalosis and digitalis related arrhythmias.
- Effects of piretanide in normal subjects.
- Bumetanide and furosemide.
- Sites of action of tripamide.
- Determinants of the overall response to furosemide: pharmacokinetics and pharmacodynamics.
- Nephron site of effect of nonsteroidal anti-inflammatory drugs on solute excretion in humans.
- Pharmacodynamics of the diuretic effects of aminophylline and acetazolamide alone and combined with furosemide in normal subjects.
- Materno-fetal transfer of azlocillin.
- Azosemide kinetics and dynamics.
- Dependence of urinary prostaglandin E2 excretion on urinary volume rather than solute handling or segmental nephron function in man.
- Bumetanide and furosemide in heart failure.
- Prolonged hemodynamic effect of furosemide in congestive heart failure.
- Pharmacodynamic considerations in the use of diuretics.
- Ceftriaxone distribution between maternal blood and fetal blood and tissues at parturition and between blood and milk postpartum.
- Clinical comparison of cimetidine and ranitidine.
- Clinical pharmacology of cefotaxime in pediatric patients.
- Treatment of severe neonatal infections with cefotaxime. Efficacy and pharmacokinetics.
- Beta-adrenergic blockade alone does not decrease renal perfusion in black hypertensives.
- Central and regional hemodynamic effects and neurohumoral consequences of minoxidil in severe congestive heart failure and comparison to hydralazine and nitroprusside.
- Clinical pharmacology of etintidine in patients with duodenal ulcer.
- Tiotidine and cimetidine--kinetics and dynamics.
- Amino acid sequence analysis of human ribosomal proteins. ORNL-4419.
- Exaggerated natriuretic and calciuric responses to hydrochlorothiazide in renal hypercalciuria but not in absorptive hypercalciuria.
- Lack of effect of prostaglandin inhibition on calcium excretion in normal volunteers.
- Mechanisms of the synergistic combination of metolazone and bumetanide.
- A Bayesian feedback method of aminoglycoside dosing.
- Furosemide absorption altered in decompensated congestive heart failure.
- Effect of doxepin on basal gastric acid and salivary secretion in patients with duodenal ulcer.
- Clearance of furosemide by the gastrointestinal tract.
- Update of cardiovascular drug interactions.
- Resistance to loop diuretics. Why it happens and what to do about it.
- High-pressure liquid chromatographic assay and pharmacokinetics of HR 810 after intramuscular injection in rabbits.
Schools
Duke University
Duke
University Calif
Doctors Specialties
- Internal Medicine
Accepted Insurances
Awards
- Whos Who in Medicine and Healthcare
Education
-
UCSF -
Duke University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Tyler L. Davis, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert J. Price, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Regan B. Esch, MD
This Doctor is OpenDoctor Recommended.
|